The loss of TβRII in breast cancer cells can enhance recruitment of F4/80+ cells to tumor microenvironment and increase the expression of pro-inflammatory genes, including CXCL1, CXCL5 and PTGS2 (cyclooxygenase-2). Here, PTGS2 is linked to breast cancer.